Oramed Pharmaceuticals Statistics
Total Valuation
ORMP has a market cap or net worth of $89.05 million. The enterprise value is -$41.29 million.
Important Dates
The next estimated earnings date is Friday, August 15, 2025, after market close.
Earnings Date | Aug 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ORMP has 40.85 million shares outstanding. The number of shares has decreased by -0.05% in one year.
Current Share Class | 40.85M |
Shares Outstanding | 40.85M |
Shares Change (YoY) | -0.05% |
Shares Change (QoQ) | +1.38% |
Owned by Insiders (%) | 14.15% |
Owned by Institutions (%) | 12.27% |
Float | 32.05M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 44.61 |
Forward PS | n/a |
PB Ratio | 0.63 |
P/TBV Ratio | 0.63 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.94, with a Debt / Equity ratio of 0.00.
Current Ratio | 23.94 |
Quick Ratio | 23.83 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -54.86 |
Financial Efficiency
Return on equity (ROE) is -18.51% and return on invested capital (ROIC) is -5.29%.
Return on Equity (ROE) | -18.51% |
Return on Assets (ROA) | -5.10% |
Return on Invested Capital (ROIC) | -5.29% |
Return on Capital Employed (ROCE) | -10.08% |
Revenue Per Employee | $153,846 |
Profits Per Employee | -$2.17M |
Employee Count | 13 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ORMP has paid $3.77 million in taxes.
Income Tax | 3.77M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.34% in the last 52 weeks. The beta is 1.62, so ORMP's price volatility has been higher than the market average.
Beta (5Y) | 1.62 |
52-Week Price Change | -15.34% |
50-Day Moving Average | 2.21 |
200-Day Moving Average | 2.30 |
Relative Strength Index (RSI) | 49.72 |
Average Volume (20 Days) | 77,171 |
Short Selling Information
The latest short interest is 475,250, so 1.16% of the outstanding shares have been sold short.
Short Interest | 475,250 |
Short Previous Month | 489,422 |
Short % of Shares Out | 1.16% |
Short % of Float | 1.48% |
Short Ratio (days to cover) | 5.71 |
Income Statement
In the last 12 months, ORMP had revenue of $2.00 million and -$28.24 million in losses. Loss per share was -$0.71.
Revenue | 2.00M |
Gross Profit | 13,000 |
Operating Income | -14.32M |
Pretax Income | 10.46M |
Net Income | -28.24M |
EBITDA | -14.15M |
EBIT | -14.32M |
Loss Per Share | -$0.71 |
Full Income Statement Balance Sheet
The company has $130.64 million in cash and $301,000 in debt, giving a net cash position of $130.34 million or $3.19 per share.
Cash & Cash Equivalents | 130.64M |
Total Debt | 301,000 |
Net Cash | 130.34M |
Net Cash Per Share | $3.19 |
Equity (Book Value) | 139.89M |
Book Value Per Share | 3.45 |
Working Capital | 125.98M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$10.46 million and capital expenditures -$19,000, giving a free cash flow of -$10.47 million.
Operating Cash Flow | -10.46M |
Capital Expenditures | -19,000 |
Free Cash Flow | -10.47M |
FCF Per Share | -$0.26 |
Full Cash Flow Statement Margins
Gross Margin | 0.65% |
Operating Margin | -715.95% |
Pretax Margin | -1,225.60% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ORMP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.05% |
Shareholder Yield | 0.05% |
Earnings Yield | -31.71% |
FCF Yield | -11.76% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | Hold |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on January 23, 2013. It was a reverse split with a ratio of 0.083333:1.
Last Split Date | Jan 23, 2013 |
Split Type | Reverse |
Split Ratio | 0.083333:1 |
Scores
ORMP has an Altman Z-Score of 6.53 and a Piotroski F-Score of 3.
Altman Z-Score | 6.53 |
Piotroski F-Score | 3 |